查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604719

首页 药物滥用检测市场：依产品类型、药物、通路 - 2025-2030 年全球预测

At-home Drug of Abuse Testing Market by Product (Blood-Based Testing Kits, Breathalyzer Testing Kits, Hair-Based Testing Kits), Test Type (Cups, Strips), Drug, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年家庭药物滥用检测市场价值为26.8亿美元，预计到2024年将达到28.8亿美元，复合年增长率为7.25%，预计到2030年将达到43.8亿美元。

家庭药物滥用检测是指市售的套件，可以让个人方便检测非法药物。对于及早发现和预防药物滥用、促进及时介入和护理至关重要。这些测试适用于家庭、职场、復健中心、执法机构等，以确保合规性和安全性。主要最终用户包括父母、雇主、缓刑官员、医疗保健提供者等，他们优先考虑保密和快速结果。药物滥用现象的日益普遍、人们对药物测试重要性的认识不断提高以及提高准确性和易用性的测试技术的进步推动了市场的成长。此外，大麻在各个地区日益合法化正在推动对 THC 特定测试产品的需求，创造利润丰厚的机会。然而，监管不确定性、结果准确性、对误报的担忧以及某些药物的检测限制等挑战阻碍了采用。此外，分散的法规环境可能会给製造商带来合规障碍。透过整合行动应用程式等数位技术并提供即时结果和指导，存在改善用户体验的潜在机会。此外，保持不同物质和药物准确性的多药物检测套组的创新预计将扩大市场基础。此外，对生物感测器技术和非侵入性测试方法的研究可能会带来重要的创新。市场竞争日益激烈，但市场分散，许多公司进入市场，从成熟的诊断公司到利基新兴企业。为了取得成功，公司必须专注于分销和意识计划的策略伙伴关係关係，以教育消费者有关家庭检测套组的重要性和可靠性。与监管机构合作确保遵守标准对于克服重大障碍至关重要。公司应该利用巨量资料分析来追踪使用模式并改善产品开发，以有效回应新的消费者需求和偏好。

主要市场统计
基准年[2023] 26.8亿美元
预计年份 [2024] 28.8亿美元
预测年份 [2030] 43.8亿美元
复合年增长率（%） 7.25%

市场动态：快速发展的家庭药物滥用检测市场的关键市场洞察

供需的动态交互作用正在改变家庭药物滥用检测市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 非法药物的使用和生产增加
    • 政府努力减少药物滥用
    • 药品生产扩大需要有效的检测措施
  • 市场限制因素
    • 无法检测少量特殊药物的测试产品
  • 市场机会
    • 新型家用药物滥用检测设备的技术进步与开发
    • 家庭药物滥用检测设备研发活动的投资
  • 市场挑战
    • 对家用药物滥用检测设备缺乏认识

波特五力：驾驭家庭药物滥用检测市场的策略工具

波特的五力框架是了解家庭药物滥用测试市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解家庭药物滥用检测市场的外部影响

外部宏观环境因素在塑造家庭药物滥用检测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解家庭药物滥用检测市场的竞争格局

家庭药物滥用测试市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵家庭药物滥用测试市场供应商的绩效评估

FPNV 定位矩阵是评估居家药物滥用测试市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製家庭药物滥用检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对家庭药物滥用检测市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 非法药物的使用和生产增加
      • 政府努力减少药物滥用
      • 扩大药品生产需要有效的检测措施
    • 抑制因素
      • 产品无法检测微量特殊药物
    • 机会
      • 技术进步与新型家用药物滥用检测设备的开发
      • 家庭药物滥用检测设备研发活动的投资
    • 任务
      • 对家用药物滥用检测设备缺乏认识
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章家庭药物滥用检测市场：副产品

  • 血液检测套组
  • 呼气分析仪检测套组
  • 头髮检测套组
  • 唾液检测套组
  • 尿液检查套件

第七章按测试类型分類的家庭药物滥用测试市场

  • 杯子
  • 条

第八章 家庭药物滥用检测市场（按药物）

  • 酒精
  • 安非他命
  • 苯二氮平类
  • 古柯碱
  • 大麻
  • 阿片类药物

第九章家庭药物滥用检测市场：依分销管道分类

  • 离线
  • 在线的

第十章美洲家庭药物滥用检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太家庭药物滥用检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲/中东/非洲家庭药物滥用检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • Accuquik by AdvaCare Pharma USA
  • Atlas Medical GmbH
  • BioMerieux, Inc.
  • Biopanda Reagents Ltd.
  • BTNX Inc.
  • Confirm BioSciences
  • Dragerwerk AG & Co. KGaA
  • Exploro Products
  • Identify Diagnostics by Medical Distribution Group, Inc.
  • Innovatek Medical Inc.
  • InTec Products, Inc.
  • Laboratory Corporation of America Holdings
  • McKesson Medical-Surgical
  • MyDiagnostics by Phyteos Helath Systems Inc.
  • myLAB Box Inc.
  • OraSure Technologies, Inc.
  • Phamatech Inc. by Caris Life Sciences
  • Psychemedics Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • UCP Biosciences Inc.
  • Vitrosens Biotechnology
  • Xiamen Boson Biotech Co., Ltd.
Product Code: MRR-B168537784E8

The At-home Drug of Abuse Testing Market was valued at USD 2.68 billion in 2023, expected to reach USD 2.88 billion in 2024, and is projected to grow at a CAGR of 7.25%, to USD 4.38 billion by 2030.

At-home drug of abuse testing refers to commercially available kits enabling individuals to test for illicit drugs privately and conveniently. They are crucial for early detection and prevention of drug misuse, facilitating immediate intervention and care. These tests find applications in households, workplaces, rehabilitation centers, and law enforcement to ensure compliance and safety. Key end-users include parents, employers, probation officers, and healthcare providers prioritizing confidentiality and rapid results. Market growth is fueled by the rising prevalence of drug abuse, increasing awareness about drug testing's importance, and advancements in testing technology which have enhanced accuracy and ease of use. Moreover, the expanding legality of cannabis in various regions stirs demand for THC-specific testing products, presenting lucrative opportunities. Nonetheless, challenges like regulatory uncertainties, concerns over result accuracy, false positives, and specific drugs' detection limitations hinder adoption. A fragmented regulatory environment across regions may also create compliance hurdles for manufacturers. The potential opportunity lies in integrating digital technologies, like mobile apps, to offer real-time results and guidance, improving user experience. Innovating multi-drug testing kits that maintain precision across different substances and drugs will also widen market reach. Furthermore, research into biosensor technology and non-invasive testing methods could yield significant innovations. The nature of the market is competitive yet fragmented with numerous players ranging from established diagnostics companies to niche startups. To thrive, companies must focus on strategic partnerships for distribution and awareness programs to educate consumers on the importance and reliability of at-home testing kits. Collaboration with regulatory bodies to ensure standards compliance will be vital in surpassing significant barriers. Businesses should leverage big data analytics to track usage patterns and improve product developments, ensuring they meet emerging consumer needs and preferences effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 2.68 billion
Estimated Year [2024] USD 2.88 billion
Forecast Year [2030] USD 4.38 billion
CAGR (%) 7.25%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving At-home Drug of Abuse Testing Market

The At-home Drug of Abuse Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing use and production of illicit drugs
    • Government initiatives to reduce drug abuse
    • Expansion of drug production necessitates effective test measures
  • Market Restraints
    • Inability of testing products to detect small amounts of special drugs
  • Market Opportunities
    • Technological advancement and development of novel at-home drug of abuse testing devices
    • Investment in R&D activities for at-home drug of abuse testing devices
  • Market Challenges
    • Lack of awareness of at-home drug of abuse testing devices

Porter's Five Forces: A Strategic Tool for Navigating the At-home Drug of Abuse Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the At-home Drug of Abuse Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the At-home Drug of Abuse Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the At-home Drug of Abuse Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the At-home Drug of Abuse Testing Market

A detailed market share analysis in the At-home Drug of Abuse Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the At-home Drug of Abuse Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the At-home Drug of Abuse Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the At-home Drug of Abuse Testing Market

A strategic analysis of the At-home Drug of Abuse Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the At-home Drug of Abuse Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuBioTech Co., Ltd., Accuquik by AdvaCare Pharma USA, Atlas Medical GmbH, BioMerieux, Inc., Biopanda Reagents Ltd., BTNX Inc., Confirm BioSciences, Dragerwerk AG & Co. KGaA, Exploro Products, Identify Diagnostics by Medical Distribution Group, Inc., Innovatek Medical Inc., InTec Products, Inc., Laboratory Corporation of America Holdings, McKesson Medical-Surgical, MyDiagnostics by Phyteos Helath Systems Inc., myLAB Box Inc., OraSure Technologies, Inc., Phamatech Inc. by Caris Life Sciences, Psychemedics Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., UCP Biosciences Inc., Vitrosens Biotechnology, and Xiamen Boson Biotech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the At-home Drug of Abuse Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Blood-Based Testing Kits, Breathalyzer Testing Kits, Hair-Based Testing Kits, Saliva-Based Testing Kits, and Urine-Based Testing Kits.
  • Based on Test Type, market is studied across Cups and Strips.
  • Based on Drug, market is studied across Alcohol, Amphetamines, Benzodiazepines, Cocaine, Marijuana, and Opioids.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing use and production of illicit drugs
      • 5.1.1.2. Government initiatives to reduce drug abuse
      • 5.1.1.3. Expansion of drug production necessitates effective test measures
    • 5.1.2. Restraints
      • 5.1.2.1. Inability of testing products to detect small amounts of special drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement and development of novel at-home drug of abuse testing devices
      • 5.1.3.2. Investment in R&D activities for at-home drug of abuse testing devices
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness of at-home drug of abuse testing devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. At-home Drug of Abuse Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Blood-Based Testing Kits
  • 6.3. Breathalyzer Testing Kits
  • 6.4. Hair-Based Testing Kits
  • 6.5. Saliva-Based Testing Kits
  • 6.6. Urine-Based Testing Kits

7. At-home Drug of Abuse Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Cups
  • 7.3. Strips

8. At-home Drug of Abuse Testing Market, by Drug

  • 8.1. Introduction
  • 8.2. Alcohol
  • 8.3. Amphetamines
  • 8.4. Benzodiazepines
  • 8.5. Cocaine
  • 8.6. Marijuana
  • 8.7. Opioids

9. At-home Drug of Abuse Testing Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Americas At-home Drug of Abuse Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific At-home Drug of Abuse Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa At-home Drug of Abuse Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AccuBioTech Co., Ltd.
  • 3. Accuquik by AdvaCare Pharma USA
  • 4. Atlas Medical GmbH
  • 5. BioMerieux, Inc.
  • 6. Biopanda Reagents Ltd.
  • 7. BTNX Inc.
  • 8. Confirm BioSciences
  • 9. Dragerwerk AG & Co. KGaA
  • 10. Exploro Products
  • 11. Identify Diagnostics by Medical Distribution Group, Inc.
  • 12. Innovatek Medical Inc.
  • 13. InTec Products, Inc.
  • 14. Laboratory Corporation of America Holdings
  • 15. McKesson Medical-Surgical
  • 16. MyDiagnostics by Phyteos Helath Systems Inc.
  • 17. myLAB Box Inc.
  • 18. OraSure Technologies, Inc.
  • 19. Phamatech Inc. by Caris Life Sciences
  • 20. Psychemedics Corporation
  • 21. Siemens Healthineers AG
  • 22. Thermo Fisher Scientific Inc.
  • 23. UCP Biosciences Inc.
  • 24. Vitrosens Biotechnology
  • 25. Xiamen Boson Biotech Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. AT-HOME DRUG OF ABUSE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. AT-HOME DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. AT-HOME DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AT-HOME DRUG OF ABUSE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AT-HOME DRUG OF ABUSE TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD-BASED TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY BREATHALYZER TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR-BASED TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA-BASED TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY URINE-BASED TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CUPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STRIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ALCOHOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY AMPHETAMINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COCAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MARIJUANA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 194. AT-HOME DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 195. AT-HOME DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023